Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system

ConclusionThis pharmacovigilance study identified several potential adverse events signals related to tremelimumab including some adverse events not listed on the drug label. However, further basic and clinical research  studies are needed to validate these results.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research